HomeCompareATWT vs JNJ

ATWT vs JNJ: Dividend Comparison 2026

ATWT yields 166666.67% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATWT wins by $7.944525992890705e+28M in total portfolio value
10 years
ATWT
ATWT
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full ATWT calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — ATWT vs JNJ

📍 ATWT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATWTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATWT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATWT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATWT
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, ATWT beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATWT + JNJ for your $10,000?

ATWT: 50%JNJ: 50%
100% JNJ50/50100% ATWT
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ATWT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATWT buys
0
JNJ buys
0
No recent congressional trades found for ATWT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATWTJNJ
Forward yield166666.67%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$7.944525992890705e+28M$30.5K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$4,749.88
Total dividends collected$7.943912645651793e+28M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ATWT vs JNJ ($10,000, DRIP)

YearATWT PortfolioATWT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,677,367$16,666,666.67$10,594$274.49+$16.67MATWT
2$25,995,051,428$25,977,206,645.90$11,294$360.69+$25995.04MATWT
3$37,869,622,473,147$37,841,807,768,118.86$12,133$476.91+$37869622.46MATWT
4$51,562,007,868,526,340$51,521,487,372,480,070.00$13,156$635.42+$51562007868.51MATWT
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$14,432$854.61+$65615852892511.91MATWT
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$16,056$1,162.76+$78042202741585760.00MATWT
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$18,175$1,604.53+$86754863367545782272.00MATWT
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$21,009$2,252.68+$9.01371089860901e+22MATWT
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$24,911$3,229.73+$8.753081018840772e+25MATWT
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$30,458$4,749.88+$7.944525992890705e+28MATWT

ATWT vs JNJ: Complete Analysis 2026

ATWTStock

ATWEC Technologies, Inc. manufactures and sells child safety solutions to schools and day care centers in Tennessee and internationally. The company's products include commercial backup system, a voice activated backup system with a sound of 115 decibals to warn the pedestrian to stand clear; KV-3 child reminder system, which helps transportation drivers to actively check their vehicles for children and seniors who may not have gotten out of the vehicle; KV-4 child reminder system, a RFID Technology that deactivates the system; KV-X sterilization system, a 2 stage sanitizer module that utilizes a UVC module to disinfect air; and KVX-4 complete child reminder system, which utilizes a UVc module to disinfect air the entire time the vehicle is operating. It also offers student tracking and notification products; Kiddie Voice, a safety alarm system for preventing the abandonment of children in a daycare bus or van; Kiddie Alert System, a back-up voice enhanced alerting system for larger motor vehicles, including buses, vans, and trucks. The company was founded in 1979 and is headquartered in Memphis, Tennessee.

Full ATWT Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ATWT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATWT vs SCHDATWT vs JEPIATWT vs OATWT vs KOATWT vs MAINATWT vs ABBVATWT vs MRKATWT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.